Texas Biodesign Workshop: Clinical Verification, Regulatory, and Reimbursement Strategy – Two Part Series (Part I)

Wednesday, April 19, 2023
4:00 – 5:30 p.m. CT on Zoom

This reimbursement workshop will include an overview of coding, coverage, and payment in the U.S.

Highlights include:

  • Coding 101
  • Payment methodologies
  • Evidence-based medicine
  • Discussion of how regulatory and clinical design can affect reimbursement
  • Case studies

JGS Group is a strategic clinical, regulatory, and reimbursement consultancy for MedTech and Life Science companies. The firm combines programs for development, implementation, and commercialization, decreasing time to the global market.

Jen Murray has been at the forefront of the reimbursement industry for more than 25 years and is the founder of the JGS Group, a full-service reimbursement, regulatory and clinical research consulting group. Since 2000, JGS has provided reimbursement consulting for new and innovative technologies ranging from startups to Fortune 100 companies.

Prior to launching the JGS Group, Jen held several positions at Covance. She served as Covance’s representative for the National AIDS Advocacy Program, working directly with the Clinton Administration on the Ryan White Fund, an initiative to secure alternative funding for AIDS/HIV patients.

Jen has authored various articles on reimbursement-related issues in such publications as the FDANews, Medical Device and Diagnostics Manufacturer’s Magazine, and Drug Information Association News. She has spoken at conferences and workshops all over the world, and was appointed to the FDANews Advisory Panel. Jen holds a Bachelors from Villanova University.